Results 41 to 50 of about 53,349 (300)

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

Systemic hematogenous dissemination of mouse oral candidiasis is induced by oral mucositis. [PDF]

open access: yes, 2018
The causes of fungemia include immunosuppression and neutropenia stemming from diverse factors as well as the placement of central venous catheters. However, the relationship between fungemia and the oral cavity has not been substantiated. In this study,
Tanaka, Akira   +7 more
core   +2 more sources

Beyond antimicrobials: Ecological nano‐strategies for rebalancing dysbiotic oral microbial homeostasis

open access: yesBMEMat, EarlyView.
Oral microbial homeostasis, a dynamic host‐microbe balance, is vital in infectious diseases. Conventional antibiotics often disrupt this homeostasis, spurring interest in nanomaterials for oral microbial homeostasis rebalancing. This review outlines nanomaterial strategies across three ecological levels (population/community, ecosystem, and cross ...
Chen Hu   +10 more
wiley   +1 more source

Avaliação dos benefícios da laserterapia no controle da dor causada pela mucosite oral radioinduzida [PDF]

open access: yes, 2014
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.RESUMO A mucosite oral é uma importante complicação que ocorre durante o tratamento radioterápico na região de cabeça e pescoço.
Guterres, Yasmim
core  

A case series of necrotizing periodontal diseases in hospitalized patients: What hasn't been said yet?

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background Necrotizing periodontal diseases (NPDs) are uncommon and severe inflammatory conditions characterized by tissue necrosis, painful ulceration, and rapid clinical progression, frequently associated with systemic immunosuppression. Limited data exist regarding their clinical presentation and management in hospital settings.
Osmaria Letthycia Carvalho Leal   +8 more
wiley   +1 more source

The therapeutic effect of PLAG against oral mucositis in hamster and mouse model

open access: yesFrontiers in Oncology, 2016
Chemotherapy-induced mucositis can limit the effectiveness of cancer therapy and increase the risk of infections. However, no specific therapy for protection against mucositis is currently available.
Ha-Reum Lee   +9 more
doaj   +1 more source

Guided bone regeneration using titanium mesh and xenogeneic graft alone: Histologic findings and 7‐year follow‐up

open access: yesClinical Advances in Periodontics, EarlyView.
Abstract Background Guided bone regeneration is a reliable technique for treating alveolar ridge deficiencies, especially in cases of severe maxillary atrophy. This case report describes the clinical management of a partially edentulous female patient presenting horizontal bone resorption in the anterior maxilla.
Bruno Freitas Mello   +3 more
wiley   +1 more source

Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study

open access: yesSouth Asian Journal of Cancer, 2014
Background: Oral mucositis is the most frequently occurring painful and dose-limiting side-effect of radiation of the head and neck region. Few studies demonstrated that oral glutamine suspension may significantly reduce the duration and severity of ...
Subrata Chattopadhyay   +4 more
doaj   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit   +6 more
wiley   +1 more source

The science of mucositis [PDF]

open access: yesSupportive Care in Cancer, 2022
Joanne Bowen, Hannah Wardill
openaire   +2 more sources

Home - About - Disclaimer - Privacy